PL EN
ORIGINAL PAPER
Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs)
 
More details
Hide details
1
Careggi University Hospital, Florence, Italy (Industrial Hygiene and Toxicology Laboratory, Occupational Medicine Unit)
2
University of Florence, Florence, Italy (Department of Experimental and Clinical Medicine)
3
Careggi University Hospital, Florence, Italy (General Laboratory)
4
Careggi University Hospital, Florence, Italy (Pharmacy AD Preparation Unit)
5
University of Florence, Florence, Italy (Department of Health Sciences)
6
Careggi University Hospital, Florence, Italy (Health and Safety Service)
CORRESPONDING AUTHOR
Stefano Dugheri   

Careggi University Hospital, Industrial Hygiene and Toxicology Laboratory, Occupational Medicine Unit, Viale Pieraccini 15, 50134 Florence, Italy
Online publication date: 2022-11-14
 
 
KEYWORDS
TOPICS
ABSTRACT
Background: Chemotherapy drugs are widely used to treat cancer, but their active compounds represent a danger for workers who could be exposed to them. However, they aren’t yet included in directive CE No. 1272/2008 and the European Biosafety Network has only recommended a limit value of 100 pg/cm2 for surface contamination. Thus, it is crucial to assess surface contaminations in healthcare environments. Currently, the technique of choice is surface wipe test combined with liquid chromatography tandem mass spectrometry to achieve high sensibility. Material and Methods: A campaign involving Careggi University Hospital (Florence, Italy) was performed from January 2020 to December 2021, collecting 1449 wipe samples between administration units, preparation unit, and personnel gloves. From the obtained data, the 90th percentile was calculated for 30 antiblastic drugs and proposed as surface exposure levels (SELs); while from data concerning personnel glove contamination, weekly contamination was estimated. Results: In the 2-year period only 417 wipe samples were found positive (28.8%), the majority of which regard samples coming from administration unit bathrooms. The proposed SELs are almost all <100 pg/cm2, except for few drugs which produce higher contamination on bathroom surfaces. Also, the estimation of pharmacy personnel’s glove contamination highlighted very low results (ng/week). Conclusions: Deeply established protocols and procedures for safe handling of ADs allow for obtaining excellent cleaning results and thus a safer work environment, however, the risk of cytostatic contaminations cannot be avoided in healthcare workplaces, and thus a harmonization of classification and labeling of chemotherapy drugs throughout the European Union should be done. Med Pr. 2022;73(5)
eISSN:2353-1339
ISSN:0465-5893